These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2507304)

  • 1. Effects of the removal of phenytoin, carbamazepine, and valproate on the electroencephalogram.
    Duncan JS; Smith SJ; Forster A; Shorvon SD; Trimble MR
    Epilepsia; 1989; 30(5):590-6. PubMed ID: 2507304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation of phenytoin, carbamazepine, and valproate in patients with active epilepsy.
    Duncan JS; Shorvon SD; Trimble MR
    Epilepsia; 1990; 31(3):324-33. PubMed ID: 2111768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antiepileptic drugs on electroencephalography (EEG): Insights and applicability.
    Limotai C; Phayaph N; Pattanasilp B; Mokklaew J; Limotai N
    Epilepsy Behav; 2020 Sep; 110():107161. PubMed ID: 32512368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiepileptic drugs and the electroencephalogram.
    Duncan JS
    Epilepsia; 1987; 28(3):259-66. PubMed ID: 2884097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interictal EEG prediction of response to antiepileptic drug monotherapy.
    Burgess RJ; Drake ME; Paulson GW
    Clin Electroencephalogr; 1985 Jul; 16(3):131-5. PubMed ID: 3930105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children.
    Herranz JL; Armijo JA; Arteaga R
    Epilepsia; 1988; 29(6):794-804. PubMed ID: 3142761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of discontinuation of phenytoin, carbamazepine, and valproate on concomitant antiepileptic medication.
    Duncan JS; Patsalos PN; Shorvon SD
    Epilepsia; 1991; 32(1):101-15. PubMed ID: 1985818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population.
    Leppik IE
    Epilepsy Res Suppl; 1988; 1():85-90. PubMed ID: 3149581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamazepine and the electroencephalogram of epileptics: a double blind study in comparison to phenytoin.
    Wilkus RJ; Dodrill CB; Troupin AS
    Epilepsia; 1978 Jun; 19(3):283-91. PubMed ID: 354922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate.
    Duncan JS; Shorvon SD; Trimble MR
    J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):924-8. PubMed ID: 3144581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum bilirubin levels with antiepileptic drugs.
    Gough H; Goggin T; Crowley M; Callaghan N
    Epilepsia; 1989; 30(5):597-602. PubMed ID: 2507305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of carbamazepine on EEG background activity and on interictal epileptiform abnormalities in focal epilepsy.
    Marciani MG; Gigli GL; Stefanini F; Sabbadini M; Stefani N; Maschio MC; Orlandi L; Bernardi G
    Int J Neurosci; 1993 May; 70(1-2):107-16. PubMed ID: 8083017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy.
    Callaghan N; Kenny RA; O'Neill B; Crowley M; Goggin T
    J Neurol Neurosurg Psychiatry; 1985 Jul; 48(7):639-44. PubMed ID: 3928820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
    Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
    Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of removal of phenytoin, carbamazepine, and valproate on cognitive function.
    Duncan JS; Shorvon SD; Trimble MR
    Epilepsia; 1990; 31(5):584-91. PubMed ID: 2119303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid function with antiepileptic drugs.
    Isojärvi JI; Pakarinen AJ; Myllylä VV
    Epilepsia; 1992; 33(1):142-8. PubMed ID: 1733749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy.
    de Silva M; MacArdle B; McGowan M; Hughes E; Stewart J; Neville BG; Johnson AL; Reynolds EH
    Lancet; 1996 Mar; 347(9003):709-13. PubMed ID: 8601999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of combination of valproic acid with diphenylhydantoin and carbamazepine in the management of intractable seizures.
    Ashok PP; Maheshwari MC
    J Assoc Physicians India; 1984 Jul; 32(7):565-7. PubMed ID: 6438054
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction of free levels of phenytoin and carbamazepine in patients comedicated with valproic acid.
    Ratnaraj N; Hjelm M
    Ther Drug Monit; 1995 Aug; 17(4):327-32. PubMed ID: 7482684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.